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Pancreaticobiliary maljunction (PBM) is a congenital anomaly deﬁned as a junction of the pancreatic
and bile ducts located outside the duodenal wall, usually forming a markedly long common channel.
Diagnosis of PBM in children is usually made by magnetic resonance cholangiopancreatography
(MRCP) or endoscopic retrograde cholangiopancreatography (ERCP). Endoscopic ultrasonography (EUS)
is a high-resolution imaging modality and a well-established diagnostic tool in adults with pan-
creaticobiliary (PB) disease. There are several articles which report the value of EUS in the diagnosis and
evaluation of PBM in adults, but there are no reports of PBM demonstrated by EUS in children. Here, we
present a case of PBM in a pediatric patient that was clearly demonstrated by EUS. EUS can be used as a
second line examination modality for demonstrating PBM in pediatric patients in whom ﬁrst line
examinations, such as MRCP or ERCP, cannot be carried out or have not been conclusive.
 2013 The Authors. Published by Elsevier Inc. Open access under CC BY license.Pancreaticobiliary maljunction (PBM) is a congenital anomaly
deﬁned as a junction of the pancreatic and bile ducts located
outside the duodenal wall. Diagnosis of PBM is usually made by
magnetic resonance cholangiopancreatography (MRCP) or endo-
scopic retrograde cholangiopancreatography (ERCP) in children.
Endoscopic ultrasonography (EUS) is a well-established diagnostic
tool in adults with pancreaticobiliary (PB) disease. There are
several articles which report the value of EUS in the diagnosis and
evaluation of PBM in adults, but there are no reports of PBM
demonstrated by EUS in children. We present a case of PBM in a
pediatric patient that was clearly demonstrated by EUS.
1. Case report
A 13-year-old Japanese girl was ﬁrst diagnosed with acute
pancreatitis at the age of 4 years. She initially presented with
epigastric pain with serum pancreatic enzyme elevations (amylase
356 IU/L, trypsin 1987 ng/mL, lipase 480 U/dL). After initial hospi-
talization and recovery of symptoms, she was followed as an
out-patient. Although PBMhadbeen suspected as the etiology of theþ81 98 974 5165.
(I. Iwama).
Inc. Open access under CC BY license.pancreatitis, deﬁnitive diagnosis had not been made. Follow-up
review of systems revealed no complaints of abdominal pain, back
pain, or fever. Her family history was unremarkable. On follow-up
examination, vital signswerenormal.Heightwas149 cmandweight
was65kg. Shewasobesewith abodymass indexof 29.Herabdomen
was soft and therewas no tenderness. The liver and spleenwere not
palpable. Laboratory studies were all within normal range. Con-
ventional abdominal ultrasonography showed dilatation of the
common bile duct (CBD) to 5.9 mm in diameter. MRCP was not able
to demonstrate a connection between the CBD and the pancreatic
duct. ERCP was not carried out due to the potential risk of compli-
cations in obese patients. EUS was then carried out in a further
attempt to visualize a connection between the CBD and the
pancreatic duct. EUS was performed with an echoendoscope
(GF-UE260, GF-UCT260, Olympus, Tokyo, Japan). The procedurewas
done with the patient in the left-sided position under intravenous
sedation with midazolam and ketamine. Continuous cardiac and
capillary oxygen saturation monitoring were carried out during the
procedure and the postprocedural period until full recovery was
achieved. EUS clearly demonstrated the PB junction to be located
outside the duodenal wall (Fig. 1). The common channel measured
16mm in length (Fig. 2). The common bile ductmeasured 4.7mm in
diameter. The gallbladder wall was thickened and there were
hyperechoic polypoid structures. PBM was highly suspected. No
complications related to the EUS occurred. We concluded that
further conﬁrmation of PBMwith ERCPwas not indicated because of
the potential for complications.
Fig. 1. EUS showed a long (16 mm) common channel (asterisk), with the PB junction
situated outside the duodenal wall. (For interpretation of the references to color in this
ﬁgure legend, the reader is referred to the web version of this article.)
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In PBM, EUS can demonstrate the conﬂuence of the pancreatic
duct and the bile duct outside the duodenal wall. It is also useful for
diagnosing other associated biliary diseases such as malignancies.
Sugiyamaet al. prospectivelyassessed thediagnostic valueof EUS for
PBM and compared it with ERCP in 188 adult patients with PB dis-
eases. On ERCP, the length of the common channel measured
23.4  5.4 mm in 25 patients with PBM and 4.1  2.0 mm in 163
patients with normal PB junction. EUS demonstrated the length of
the common channel in 25 patients with PBM to be12mm in 88%.
In contrast, in patients with a normal junction, the channel was
<6mm on EUS. Sugiyama et al. also noted that EUS was valuable for
detecting PB diseases associated with PBM such as PB carcinoma,
gallbladder lesions, and congenital choledochal cysts. They
concluded that EUS plays an adjunctive role in the evaluation of
patients with PBM [1]. ERCP depicts PBMmore reliably than EUS but
ismore invasivewith a greater potential risk ofmorbidity. The rate of
complications secondary to ERCP is 2.5%e10% in children [2e4].
Cotton et al. reported that obesity is one of the risk factors for severeFig. 2. Black arrowhead common bile duct; white arrowhead main pancreatic duct.
(For interpretation of the references to color in this ﬁgure legend, the reader is referred
to the web version of this article.)or fatal complications with ERCP [5]. We felt that ERCP was not
indicated in our patient because of its potential for complications
and because ERCP would likely not provide more information than
had already been obtained by EUS.
There are six reports regarding the use of EUS in gastrointestinal
disease in children [6e11]. These reports demonstrate that EUS
exams can be carried out without complications, even in small
children. These authors concluded that EUS is a safe and useful
examination modality in children. According to these reports, EUS
was used mainly for the evaluation of pancreatic diseases (e.g.,
recurrent pancreatitis and cysts/tumors of the pancreas) or sub-
mucosal lesions of the gastrointestinal tract. There were no cases of
PBM in those reports. To our knowledge there are no previously
published case reports of the use of EUS in diagnosing PBM in
children.
3. Conclusion
We suggest that EUS can be used as a second line examination
modality for demonstrating PBM in pediatric patients inwhom ﬁrst
line examinations, such as MRCP or ERCP, have not been conclusive
or carry high risk.
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